Renal denervation: What happened, and why?
- PMID: 28885911
- DOI: 10.3949/ccjm.84a.14129
Renal denervation: What happened, and why?
Abstract
Despite promising results in initial trials, renal denervation failed to achieve its efficacy end points as a treatment for resistant hypertension in the SYMPLICITY HTN-3 trial, the largest trial of this treatment to date (N Engl J Med 2014; 370:1393-1401). Is renal denervation dead, or will future trials and newer technology revive it?
Copyright © 2017 Cleveland Clinic.
Comment in
-
Renal denervation: Are we on the right path?Cleve Clin J Med. 2017 Sep;84(9):687-689. doi: 10.3949/ccjm.84a.17024. Cleve Clin J Med. 2017. PMID: 28885900 No abstract available.
Comment on
-
A controlled trial of renal denervation for resistant hypertension.N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29. N Engl J Med. 2014. PMID: 24678939 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources